NIPPON INDIA PHARMA FUND vs TATA INDIA PHARMA & HEALTHCARE FUND
Nippon vs Tata· Portfolio Overlap Analysis
58.2%High Overlap
20 common stocksRank #5824 / 20,000
Investor takeaway: At 58.2% overlap, a significant part of these portfolios is identical. Despite coming from different AMCs, the stock picks still converge heavily. Make sure both funds actually serve different jobs in your allocation.
Common Holdings (20)
| Stock | Wt% in NIPPON INDIA PHARMA | Wt% in TATA INDIA PHARMA & HEALTHCARE | Overlap |
|---|---|---|---|
Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology | 13.08% | 9.66% | 9.66% |
Divi's Laboratories Limited Pharmaceuticals & Biotechnology | 6.56% | 5.94% | 5.94% |
Apollo Hospitals Enterprise Limited Healthcare Services | 5.17% | 5.00% | 5.00% |
Cipla Limited Pharmaceuticals & Biotechnology | 5.67% | 4.55% | 4.55% |
Max Healthcare Institute Limited Healthcare Services | 3.49% | 6.78% | 3.49% |
Lupin Limited Pharmaceuticals & Biotechnology | 7.99% | 3.08% | 3.08% |
Sai Life Sciences Limited Pharmaceuticals & Biotechnology | 3.07% | 3.25% | 3.07% |
Mankind Pharma Limited Pharmaceuticals & Biotechnology | 3.06% | 3.40% | 3.06% |
Dr. Reddy's Laboratories Limited Pharmaceuticals & Biotechnology | 5.81% | 3.04% | 3.04% |
Abbott India Limited Pharmaceuticals & Biotechnology | 2.37% | 5.60% | 2.37% |
Alkem Laboratories Limited Pharmaceuticals & Biotechnology | 2.20% | 2.15% | 2.15% |
Ajanta Pharma Limited Pharmaceuticals & Biotechnology | 3.41% | 2.06% | 2.06% |
Dr. Lal Path Labs Limited Healthcare Services | 2.05% | 2.71% | 2.05% |
JB Chemicals & Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 1.98% | 3.21% | 1.98% |
GlaxoSmithKline Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 2.83% | 1.82% | 1.82% |
Vijaya Diagnostic Centre Limited Healthcare Services | 3.49% | 1.55% | 1.55% |
Fortis Healthcare Limited Healthcare Services | 1.25% | 3.27% | 1.25% |
Sanofi India Limited Pharmaceuticals & Biotechnology | 1.10% | 1.99% | 1.10% |
Syngene International Limited Healthcare Services | 0.96% | 2.39% | 0.96% |
IPCA Laboratories Limited Pharmaceuticals & Biotechnology | 2.51% | 0.00% | 0.00% |
Unique to NIPPON INDIA PHARMA
- MedPlus Health Services Limited3.70%
Unique to TATA INDIA PHARMA & HEALTHCARE
- HEALTHCARE GLOBAL ENTERPRISES LTD.5.04%
- RAINBOW CHILDRENS MEDICARE LTD.3.83%
- BAYER CROPSCIENCE LTD.3.33%
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology43.9% (14)
Healthcare Services14.3% (6)
More comparisons for NIPPON INDIA PHARMA
- vs Motilal Oswal BSE Healthcare E64.5% · 33 stocks
- vs Mirae Asset Nifty 500 Healthca63.7% · 27 stocks
- vs ADITYA BIRLA SUN LIFE PHARMA &61.7% · 25 stocks
- vs DSP Nifty Healthcare ETF59.2% · 15 stocks
- vs ADITYA BIRLA SUN LIFE NIFTY HE59.2% · 15 stocks
More comparisons for TATA INDIA PHARMA & HEALTHCARE
- vs Mirae Asset Nifty 500 Healthca58.6% · 27 stocks
- vs Motilal Oswal BSE Healthcare E56.7% · 32 stocks
- vs Kotak Healthcare55.0% · 18 stocks
- vs Baroda BNP Paribas Health and 51.0% · 17 stocks
- vs PGIM INDIA HEALTHCARE50.9% · 16 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.